MediWound Ltd.

NASDAQ:MDWD

Biotechnology

Healthcare
$13.61 -0.60%

-$0.09 today

Market cap
$175.71M
Beta
0.15
P/E (TTM)
-7.0
EPS (TTM)
-$2.03
52W Low $13.54High $21.26

Volume 0.17M

Average 0.09M

MDWD Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

MediWound Ltd.NASDAQ: MDWD

Weighted Avg Shares (Diluted) · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares (diluted) growth accelerates

Q1 FY2026 weighted avg shares (diluted) of 12.87M shares rose 19.2% year over year, ahead of the +14.9% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it rose 0.4% from the prior quarter. Over 3 fiscal years it compounded at +31.6% a year.

Context

  • Weighted avg shares (diluted) increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +19.2% holds above the trailing-twelve-month pace of +14.9%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
12.87M+0.4% QoQ
Last fiscal yearDec 2025
11.38M+14.2% YoY
LTMMar 2026
11.89M+14.9% YoY
Weighted Avg Shares (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+19.2%——
1 year+14.2%——
3-year CAGR+31.6%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares (Diluted) history

Shares · from the income statement

Latest · FY2025
11.38M USD
Year-over-year change
+14.2%
4-year CAGR
+30.8%

Weighted Avg Shares (Diluted) vs competitors

How MDWD compares with its peers on the latest reported figures

  • MDWD's LTM Mar 2026 weighted avg shares (diluted) of 11.89M shares is the lowest of the 10 companies compared; the peer median is 43.36M shares.
  • Its year-over-year change of +14.9% is the 7th highest of 9, against a peer median of +42.0%.
  • Over three fiscal years its annual growth of +31.6% compares with a peer median of +41.8%.
MDWD Competitors Peer median
Weighted Avg Shares (Diluted) for MDWD and competitors
Company Period LTM YoY 3-year CAGR
IVVDInvivyd, Inc.LTM Mar 2026193.02M +61.8%+16.7%
IVAInventiva S.A.FY2025186.8M +259.4%+65.2%
SLSSELLAS Life Sciences Group, Inc.LTM Sep 2026179.3M +94.5%+77.8%
EPRXEupraxia Pharmaceuticals Inc.LTM Mar 202645.37M +27.3%+27.5%
TARAProtara Therapeutics, Inc.LTM Mar 202643.36M +56.7%+56.1%
OBIOOrchestra BioMed Holdings, Inc.LTM Mar 202638.39M +2.6%+14.7%
RNACCartesian Therapeutics, Inc.LTM Mar 202626.32M +15.6%+85.8%
AARDAardvark Therapeutics, Inc. Common StockLTM Mar 202621.77M +1.1%+0.7%
NTHINeonc Technologies Holdings, Inc.LTM Mar 202620.19M ——
MDWDMediWound Ltd.LTM Mar 202611.89M +14.9%+31.6%
Peer median (excluding MDWD) 43.36M+42.0%+41.8%

Competitors are the stored peer set for MDWD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue23.76M26.5M18.69M20.22M16.96M
Cost of Revenue14.99M13.33M15.11M17.59M13.71M
Gross Profit8.77M13.17M3.58M2.63M3.25M
Gross Margin36.9%49.7%19.1%13.0%19.2%
Research & Development10.26M10.18M7.47M8.88M14.32M
Selling, General & Admin9.45M10.37M11.38M12.91M13.93M
Operating Expenses19.99M20.83M19.08M22.02M28.53M
Depreciation & Amortization1.24M1.27M1.3M1.48M1.86M
EBITDA(11.38M)(18.25M)(4.8M)(27.93M)(21.47M)
EBITDA Margin-47.9%-68.9%-25.7%-138.1%-126.6%
Operating Income(11.22M)(7.66M)(15.5M)(19.38M)(25.28M)
Operating Margin-47.2%-28.9%-83.0%-95.8%-149.1%
Interest Income11K270K2.34M2.05M1.86M
Interest Expense167K162K335K561K663K
Other Income / Expenses(2.3M)(11.86M)8.97M(10.78M)1.57M
Income Before Tax(13.52M)(19.52M)(6.53M)(30.16M)(23.71M)
Pre-Tax Margin-56.9%-73.7%-35.0%-149.2%-139.8%
Income Tax Expense27K78K185K61K169K
Net Income(13.55M)(19.6M)(6.72M)(30.22M)(23.88M)
Net Margin-57.0%-74.0%-35.9%-149.5%-140.8%
EPS (Basic)(3.48)(3.93)(0.75)(3.03)(2.10)
EPS (Diluted)(3.48)(3.93)(0.75)(3.03)(2.10)
Weighted Avg Shares3.89M4.99M9.01M9.96M11.38M
Weighted Avg Shares (Diluted)3.89M4.99M9.01M9.96M11.38M

MediWound Ltd.

NASDAQ:MDWD

Intrinsic Alpha fair value

Locked

Current Price

$13.61

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.